Authors


David Kim, PharmD, MPh

Latest:

Migraine-Specific Biologics Treat Severe Headaches

Approved agents target calcitonin gene-related peptides to bring pain relief to affected patients.


Rebecca A. Jayakumar, PharmD

Latest:

Baloxavir Marboxil Treats Acute Influenza in Otherwise Healthy Patients

The newly FDA-approved drug blocks viral replication and RNA transcription via a cap-dependent endonuclease inhibitor.


Thao M. Cong, PharmD Candidate, Cinda Wu, PharmD Candidate

Latest:

Incorporating Vaccination Services into Your Practice

Pharmacists can help achieve immunization goals?especially with influenza and pneumococcal vaccinations?by becoming immunization advocates, facilitators, and/or active immunizers.


Philio D. Hansten, PharmD

Latest:

Does Linezolid Interact with Warfarin?

The antibacterial agent linezolid would not be expected to participate in drug–drug interactions via the cytochrome P450 (CYP) system because it does not appear to be a substrate, inhibitor, or inducer of such isozymes.


Kristen Crossley, Managing Editor

Latest:

FDA Collaborates With Tech Company to Analyze COVID-19 Data

The FDA and Aetion have announced an agreement to collaborate on advanced analytical techniques in an effort to answer urgent research questions about COVID-19.


Sameer Ghate, PhD

Latest:

Resource Use Among Nonvalvular Atrial Fibrillation Patients

This study assesses comparative resource use for patients given a new diagnosis of nonvalvular atrial fibrillation treated with dabigatran or warfarin in a real-world setting.




Ruth T. Aguiar, BA

Latest:

Factors Associated With Employee Participation in a Value-Based Insurance Design Initiative

We describe enrollment in a voluntary VBID initiative. Uptake was suboptimal, suggesting that barriers to enrollment may have significant implications for the overall effectiveness of VBID.


Alesia Sadosky, PhD, MPH, MBA

Latest:

Trends Associated with Implementing and Lifting a Pregabalin Step Therapy Policy

This study examined the impact of a pregabalin step therapy policy on utilization and medical costs in Humana’s Medicare and commercial plans.


Cate Sibley, PharmD

Latest:

Keys to Creating a Healthier and Longer Life

Discover nine overlapping eating habits and lifestyle practices that can help create a healthier, happier, and longer life.


Scott Kemme, SVP, Pharmaceutical Technology & Innovation, McKesson

Latest:

What’s Ahead? Pharmacy Technology Will Drive Patient Care

The pharmacist plays a critical role in supporting the care plan developed between the patient and the physician.


Hemant Phatak, PhD

Latest:

Economic Outcomes of Warfarin Discontinuation Among Patients with Atrial Fibrillation

This study seeks to determine the economic effects of warfarin discontinuation in patients with nonvalvular atrial fibrillation.


Gina Columbus

Latest:

Dasatinib Approved for Treatment of Certain Pediatric Patients

The FDA has approved dasatinib (Sprycel, Briston-Myers Squibb) tablets in combination with chemotherapy for the treatment of pediatric patients ≥1 year of age with newly diagnosed Philadelphia chromosome-positive (Ph+) acute lymphoblastic leukemia (ALL).


Kimberly Won, PharmD, BCCCP

Latest:

Vaccinating Adults Amid Crisis Poses Challenges

Pharmacists can greatly contribute to herd immunity during this unprecedented health crisis.



Jamie Rickards, PharmD, MBA, BCPS, CPP

Latest:

JNC 8 and Older Adults: A Review of the Evidence

New Guideline for Blood Pressure Management in Older Patients


Susanna Matter, MA, MBA

Latest:

Burden of Autosomal Dominant Polycystic Kidney Disease: Systematic Literature Review

The authors present a review of the literature for autosomal dominant polycystic kidney disease to characterize its impact on patients and healthcare systems.


Yvetter C. Terrie, BSPharm, RPh

Latest:

Pulmonary Arterial Hypertension: Keeping Patients Informed

Arming patients with essential knowledge about pulmonary arterial hypertension empowers them to make informed decisions about their health.


Kaelen Dunican, RPh, PharmD

Latest:

Double Dosing: Helping Patients Understand the Risks During Cold Season

It’s a good time to talk to patients about the potential risks of taking over-the- counter (OTC) cold and flu medication and other OTC or prescription analgesics and antipyretics concomitantly.



By Sandra Kear

Latest:

Talking with Patients about Opioid Risks and Safety

Open communication between patients and care providers--including pharmacists--is critical in ensuring the safe use of opioids.


Gregory Hess

Latest:

Innovations in Education

Roosevelt University College of Pharmacy offers a unique 3-year program with state-of-the-art facilities.



Erin Kelley, PharmD, BCOP

Latest:

New Combination Therapies for the Treatment of Chronic Lymphocytic Leukemia

Patients with CLL may have genetic mutations that predict response to different treatments.


Fred M. Eckel, RPh, MS, ScD (Hon) Pharmacy Times Editor-in-Chief

Latest:

It's Time to Say Good-bye

Thank you all for your support and encouragement, but it is now time for me to put this part of my career in the past.



Stacey Ness, PharmD, RPh, MSCS, AAHIVP

Latest:

Specialty Pharmacy Considerations for Oral Multiple Sclerosis Therapies

Multiple sclerosis treatment options have expanded dramatically over the past several years. In addition to subcutaneous and intravenous medications, there are now 3 disease-modifying oral therapies available in the United States.


Mary Wagner, PharmD, MS

Latest:

Effective Drug Therapy for Epilepsy

Understanding the drug interactions associated with antiepileptic drugs can avoid complications.